ALBERTI SAVERIO has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are PROFOS AG, UNI FUR BODENKULTUR WIEN and HYGLOS INVEST GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Alberti Saverio | 15 |
#2 | Guerra Emanuela | 9 |
#3 | Trerotola Marco | 1 |
#4 | Sese Antonio | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013171777A2 | Use of trop-2 as predictive marker of response to anti-tumor therapy based on inhibitors of cd9, akt and molecules of the tetraspanin signalling network | |
US2011213015A1 | Oligonucleotidic sequences able to silence the expression of the CYCLIN D1-TROP2 chimera and uses thereof in medical field | |
US2012052076A1 | Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors |